In October 2022 the FDA put hearing aids on the shelf. Years on, the category is still widely misunderstood — starting with the single word that defines who it's for.
The healthy-aging aisle has never been louder — a new “miracle” every week, and a new reason to be skeptical. Our job is simpler than it sounds: read the studies in full, separate proven from promoted, and say plainly what's worth your attention. Right now that means hearing, memory, and joint health after fifty — all read the same way: what the research supports, and what it doesn't.

One of the most repeated claims in the category, measured against the trial built to test it. Association is well established; prevention is a separate question — and a harder one.
The best-selling memory supplement in the world, measured against the largest and longest trials ever run on it. The answer isn't what the packaging implies.

The best-selling joint ingredients in the world, measured against the largest trial the NIH could build — and its two-year follow-up. The result is more useful than the label copy, and less flattering.
We read the research so you don't have to — then tell you what it actually means.
Aeverest joins aevum — the Latin root of longevity, a life in its full span — to Everest, the summit. Together they make a quiet argument: that your peak, in health and in mind, is not a place you left behind but one still worth climbing toward. Our mark draws the Æ as that summit, first light on its face.
About the Report →